BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21183275)

  • 1. Thyroid hormone as a regulator of tumor induced angiogenesis.
    Pinto M; Soares P; Ribatti D
    Cancer Lett; 2011 Feb; 301(2):119-26. PubMed ID: 21183275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
    Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
    Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nongenomic actions of thyroid hormone.
    Davis PJ; Leonard JL; Davis FB
    Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone and angiogenesis.
    Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
    Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
    Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
    Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
    Lin HY; Su YF; Hsieh MT; Lin S; Meng R; London D; Lin C; Tang HY; Hwang J; Davis FB; Mousa SA; Davis PJ
    FASEB J; 2013 Aug; 27(8):3209-16. PubMed ID: 23640055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
    Cohen K; Ellis M; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
    Mol Cancer Res; 2011 Oct; 9(10):1385-94. PubMed ID: 21821675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.
    Liu YC; Yeh CT; Lin KH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
    Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
    Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management.
    Mousa SA; Lin HY; Tang HY; Hercbergs A; Luidens MK; Davis PJ
    Angiogenesis; 2014 Jul; 17(3):463-9. PubMed ID: 24458693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
    Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
    Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology.
    Hercbergs AH; Ashur-Fabian O; Garfield D
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):432-6. PubMed ID: 20689420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
    Davis PJ; Davis FB; Lin HY; Mousa SA; Zhou M; Luidens MK
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1238-46. PubMed ID: 19755667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
    Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
    PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.
    Davis PJ; Davis FB; Lin HY
    Steroids; 2008 Oct; 73(9-10):1013-7. PubMed ID: 18329679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How thyroid hormone works depends upon cell type, receptor type, and hormone analogue: implications in cancer growth.
    Davis PJ; Lin HY; Hercbergs AA; Keating KA; Mousa SA
    Discov Med; 2019 Feb; 27(147):111-117. PubMed ID: 30939295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of thyroid hormones during development: Focus on signal transduction.
    Scapin S; Leoni S; Spagnuolo S; Gnocchi D; De Vito P; Luly P; Pedersen JZ; Incerpi S
    Steroids; 2010; 75(8-9):576-84. PubMed ID: 19900468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
    Lin HY; Mousa SA; Davis PJ
    Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
    Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
    Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.